Burgess-Hull Albert J, Smith Kirsten E, Schriefer Destiny, Panlilio Leigh V, Epstein David H, Preston Kenzie L
National Institute on Drug Abuse Intramural Research Program, 251 Bayview Blvd., Baltimore, MD, 21224, USA.
National Institute on Drug Abuse Intramural Research Program, 251 Bayview Blvd., Baltimore, MD, 21224, USA.
Drug Alcohol Depend. 2021 Sep 1;226:108884. doi: 10.1016/j.drugalcdep.2021.108884. Epub 2021 Jun 25.
We previously showed, in people starting treatment for opioid use disorder (OUD), that stress is neither necessary nor sufficient for lapses to drug use to occur, despite an association between the two. Both theoretical clarity and case-by-case prediction accuracy may require initial differentiation among patients.
To examine: (a) evidence for distinct overall trajectories of momentary stress during OUD treatment, (b) relationships between stress trajectory and treatment response, and (c) relationships between stress trajectory and momentary changes in stress and craving prior to lapses.
We used ecological momentary assessment (EMA) to collect ratings of stress and craving 3x/day for up to 16 weeks in 211 outpatients during agonist treatment for OUD. With growth mixture models, we identified trajectories of stress. We used mixed effect models to examine trajectory-group differences in the dynamics of stress and craving just before lapses to any drug use.
We identified four trajectories of stress: Increasing (13.7 %); Moderate and Stable (23.7 %); Declining and Increasing (18 %); and Low (44.6 %). Overall drug use and opioid craving were lowest in the Low Stress group. Overall drug use was highest in the Moderate and Stable group. Alcohol use and opioid craving were highest in the Increasing Stress group. Opioid craving increased before lapse for most groups, but stress increased before lapses for only the Moderate and Stable group.
There are natural groupings of participants with distinct patterns of stress severity during OUD treatment. Momentary stress/craving/lapse associations may be better characterized when these groupings are considered first.
我们之前在开始接受阿片类物质使用障碍(OUD)治疗的人群中发现,尽管压力与复吸药物使用之间存在关联,但压力对于复吸的发生既非必要条件也非充分条件。理论清晰度和个案预测准确性可能都需要对患者进行初步区分。
研究:(a)OUD治疗期间瞬间压力的不同总体轨迹的证据;(b)压力轨迹与治疗反应之间的关系;(c)压力轨迹与复吸前压力和渴望的瞬间变化之间的关系。
我们使用生态瞬时评估(EMA),在211名接受OUD激动剂治疗的门诊患者中,每天3次收集压力和渴望评分,持续长达16周。通过生长混合模型,我们确定了压力轨迹。我们使用混合效应模型来检验在复吸任何药物使用之前,压力和渴望动态变化中的轨迹组差异。
我们确定了四种压力轨迹:上升型(13.7%);中度且稳定型(23.7%);下降后上升型(18%);以及低压力型(44.6%)。低压力组的总体药物使用和阿片类物质渴望最低。中度且稳定组的总体药物使用最高。上升压力组的酒精使用和阿片类物质渴望最高。大多数组在复吸前阿片类物质渴望增加,但只有中度且稳定组在复吸前压力增加。
在OUD治疗期间,参与者存在自然分组,其压力严重程度模式各不相同。在考虑这些分组后,瞬间压力/渴望/复吸关联可能会得到更好的描述。